InvestorsObserver
×
News Home

Can Reata Pharmaceuticals Inc (RETA) Stock Rise to the Top of Healthcare Sector Wednesday?

Wednesday, September 20, 2023 01:08 PM | InvestorsObserver Analysts

Mentioned in this article

Can Reata Pharmaceuticals Inc (RETA) Stock Rise to the Top of Healthcare Sector Wednesday?

Reata Pharmaceuticals Inc (RETA) is near the top in its sector according to InvestorsObserver. RETA gets an overall rating of 90. That means it scores higher than 90% of stocks. Reata Pharmaceuticals Inc gets a 87 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

Overall Score - 90
RETA has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on RETA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 90 would rank higher than 90 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Reata Pharmaceuticals Inc Stock Today?

Reata Pharmaceuticals Inc (RETA) stock is trading at $172.18 as of 1:07 PM on Wednesday, Sep 20, a rise of $0.07, or 0.04% from the previous closing price of $172.11. Volume today is less active than usual. So far 284,523 shares have traded compared to average volume of 727,076 shares. The stock has traded between $172.10 and $172.21 so far today. Click Here to get the full Stock Report for Reata Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App